Rigel Pharmaceuticals
RIGL
#7162
Rank
S$0.68 B
Marketcap
S$37.14
Share price
-9.12%
Change (1 day)
44.19%
Change (1 year)

Earnings for Rigel Pharmaceuticals (RIGL)

Earnings in 2025 (TTM): S$0.15 Billion

According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are S$0.28 Billion. In 2024 the company made an earning of S$33.64 Million, an increase over its 2023 earnings that were of -S$23.33 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rigel Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$0.15 B369.5%
2024 S$33.64 M-244.27%
2023 -S$23.33 Million-66.79%
2022 -S$70.24 Million340.73%
2021 -S$15.94 Million-56.15%
2020 -S$36.35 Million-57.34%
2019 -S$85.21 Million-7.66%
2018 -S$92.28 Million-9.47%
2017 -S$0.11 Billion24.46%
2016 -S$81.9 Million23.63%
2015 -S$66.25 Million-43.29%
2014 -S$0.12 Billion2.5%
2013 -S$0.12 Billion
2010 S$48.46 M-133.97%
2009 -S$0.15 Billion-18.49%
2008 -S$0.18 Billion71.91%
2007 -S$0.11 Billion84.74%
2006 -S$55.11 Million-10.17%
2005 -S$61.35 Million-15.73%
2004 -S$72.81 Million39.29%
2003 -S$52.27 Million10.3%
2002 -S$47.39 Million48.3%
2001 -S$31.96 Million-2.13%
2000 -S$32.66 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
S$11.63 B 7,353.80%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$18.77 B 11,928.45%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
-S$0.14 Billion-189.43%๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI.defunct
-S$0.17 Billion-207.13%๐Ÿ‡บ๐Ÿ‡ธ USA